Necroptosis in Immuno-Oncology and Cancer Immunotherapy

Immune-checkpoint blockers (ICBs) have revolutionized oncology and firmly established the subfield of immuno-oncology. Despite this renaissance, a subset of cancer patients remain unresponsive to ICBs due to widespread immuno-resistance. To “break” cancer cell-driven immuno-resistance, researchers h...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Cells
Autors principals: Sprooten, Jenny, De Wijngaert, Pieter, Vanmeerbeek, Isaure, Martin, Shaun, Vangheluwe, Peter, Schlenner, Susan, Krysko, Dmitri V., Parys, Jan B., Bultynck, Geert, Vandenabeele, Peter, Garg, Abhishek D.
Format: Artigo
Idioma:Inglês
Publicat: MDPI 2020
Matèries:
Review
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7464343/
https://ncbi.nlm.nih.gov/pubmed/32752206
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cells9081823
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars